Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyridostigmine + Silodosin for Acute Urinary Retention in BPH
NCT06319469Phase 2Completed
- Sponsor
- Beni Suef University
- Start
- Feb 2023
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pyridostigmine in acute urinary retention, sponsored by Beni Suef University. Started Feb 2023; status: completed.
02
Drugs
pyridostigmine
03
Conditions
acute urinary retention
Beyond the preview
Go deeper on NCT06319469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06319469.